Nuclear factor-B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner

Laboratory Investigation

Volumn 91, Issue 6, 2011, Pages 859-871

  Yeramian, Andree ^a   Santacana, Maria ^a   Sorolla, Anabel ^a   Llobet, David ^a   Encinas, Mario ^b   Velasco, Ana ^a   Bahi, Nuria ^a   Eritja, Nuria ^a   Domingo, Mónica ^a   Oliva, Esther ^c   Dolcet, Xavier ^a   Matias Guiu, Xavier ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

apoptosis; hypoxia; IKKa; IKKb; NF B

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P100; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR RELA; BROXURIDINE; HIF1A PROTEIN, MOUSE; I KAPPA B KINASE; LUCIFERASE; PRIMER DNA; RELA PROTEIN, MOUSE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; ENDOMETRIUM CARCINOMA; FIBROBLAST; HYPOXIA; IMMUNOHISTOCHEMISTRY; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; RADIOTHERAPY; ANIMAL; APOPTOSIS; CELL HYPOXIA; ENDOMETRIUM TUMOR; FEMALE; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; MICROARRAY ANALYSIS; PHYSIOLOGY; PLASMID; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL HYPOXIA; CELL LINE, TUMOR; DNA PRIMERS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; LUCIFERASES; MICE; MICROARRAY ANALYSIS; NF-KAPPA B P52 SUBUNIT; PLASMIDS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 79957593648     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.58     Document Type: Article

References (44)

1. Harris AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47. (Pubitemid 37328806)
2. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-39. (Pubitemid 26396294)
3. Vaupel P, Kelleher DK, Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001;28(2 Suppl 8):29-35. (Pubitemid 32522235)
4. Rius J, Guma M, Schachtrup C, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF- 1alpha. Nature 2008;453:807-811. (Pubitemid 351793778)
5. Kazi AA, Koos RD. Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 2007;148:2363-2374. (Pubitemid 46997054)
6. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468-472. (Pubitemid 32335942)
7. Semenza GL. Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 2000;59:47-53.
8. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
9. Dolcet X, Llobet D, Encinas M, et al. Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants. J Biol Chem 2006;281:22118-22130. (Pubitemid 44181916)
10. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260. (Pubitemid 28183365)
11. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000;18:621-663. (Pubitemid 30365393)
12. Li ZW, Chu W, Hu Y, et al. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999;189:1839-1845. (Pubitemid 29272700)
13. Senftleben U, Cao Y, Xiao G, et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001;293:1495-1499. (Pubitemid 32801552)
14. Pallares J, Martinez-Guitarte JL, Dolcet X, et al. Abnormalities in the NFkappaB family and related proteins in endometrial carcinoma. J Pathol 2004;204:569-577. (Pubitemid 39585956)
15. Pansare V, Munkarah AR, Schimp V, et al. Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas. Mod Pathol 2007;20:35-43. (Pubitemid 44967948)
16. Catasus L, Machin P, Matias-Guiu X, et al. Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Hum Pathol 1998;29:1160-1164. (Pubitemid 28467540)
17. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009;105:109.
18. Sorolla A, Yeramian A, Dolcet X, et al. Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanomaderived cell lines. Br J Dermatol 2008;158:496-504. (Pubitemid 351239183)
19. Goda N, Ryan HE, Khadivi B, et al. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003;23:359-369. (Pubitemid 36008526)
20. Swanton C. Cell-cycle targeted therapies. Lancet Oncol 2004;5:27-36. (Pubitemid 38072557)
21. Walmsley SR, Print C, Farahi N, et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 2005;201:105-115. (Pubitemid 40130088)
22. Liu XH, Yu EZ, Li YY, et al. HIF-1alpha has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression. J Cell Biochem 2006;97:755-765.
23. Scortegagna M, Cataisson C, Martin RJ, et al. HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Blood 2008;111:3343-3354.
24. Rosenbaum DM, Michaelson M, Batter DK, et al. Evidence for hypoxiainduced, programmed cell death of cultured neurons. Ann Neurol 1994;36:864-870. (Pubitemid 24370925)
25. Wen W, Ding J, Sun W, et al. Suppression of cyclin D1 by hypoxiainducible factor-1 via direct mechanism inhibits the proliferation and 5-fluorouracil-induced apoptosis of A549 cells. Cancer Res 2010;70: 2010-2019.
26. Lluis JM, Buricchi F, Chiarugi P, et al. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor- {kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res 2007;67:7368-7377. (Pubitemid 47206567)
27. Zandi E, Rothwarf DM, Delhase M, et al. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91: 243-252. (Pubitemid 27456391)
28. Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999;284:316-320.
29. Takaesu G, Surabhi RM, Park KJ, et al. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J Mol Biol 2003;326:105-115. (Pubitemid 36279361)
30. Solt LA, Madge LA, Orange JS, et al. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta. J Biol Chem 2007;282:8724-8733. (Pubitemid 47093521)
31. Mordmuller B, Krappmann D, Esen M, et al. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a cotranslational mechanism. EMBO Rep 2003;4:82-87. (Pubitemid 36305383)
32. Xiao G, Fong A, Sun SC. Induction of p100 processing by NF-kappaBinducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J Biol Chem 2004;279:30099-30105. (Pubitemid 38937932)
33. Xiao G, Harhaj EW, Sun SC. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 2001;7:401-409. (Pubitemid 32206507)
34. Dejardin E, Droin NM, Delhase M, et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002;17:525-535. (Pubitemid 35223540)
35. Coope HJ, Atkinson PG, Huhse B, et al. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J 2002;21:5375-5385. (Pubitemid 35231017)
36. Caamano JH, Rizzo CA, Durham SK, et al. Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cellmediated immune responses. J Exp Med 1998;187:185-196. (Pubitemid 28060434)
37. Nadiminty N, Lou W, Lee SO, et al. Stat3 activation of NF-{kappa}B p100 processing involves CBP/p300-mediated acetylation. Proc Natl Acad Sci USA 2006;103:7264-7269. (Pubitemid 43727821)
38. Gustin JA, Korgaonkar CK, Pincheira R, et al. Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52. J Biol Chem 2006;281:16473- 16481.
39. Lee SM, Lee CT, Kim YW, et al. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells. Cancer Lett 2006;242:231-238. (Pubitemid 44485304)
40. Noman MZ, Buart S, Van Pelt J, et al. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J Immunol 2009;182:3510-3521.
41. Sun SC, Ganchi PA, Beraud C, et al. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc Natl Acad Sci USA 1994;91:1346-1350.
42. Lessard L, Saad F, Le Page C, et al. NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells. Cell Signal 2007;19:1093-1100. (Pubitemid 46436443)
43. Anest V, Hanson JL, Cogswell PC, et al. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 2003;423:659-663. (Pubitemid 36713228)
44. Luo JL, Tan W, Ricono JM, et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007;446:690-694. (Pubitemid 46606879)